Literature DB >> 2145990

Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay.

C E van der Schoot1, T W Huizinga, E T van 't Veer-Korthof, R Wijmans, J Pinkster, A E von dem Borne.   

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a disease that affects not only red cells, but other blood cells as well. The common defect is supposed to be an acquired deficiency of glycosyl-phosphatidylinositol (GPI)-anchored membrane proteins, which may be present already at the hematopoietic stem cell level. Recently, a panel of monoclonal antibodies (MoAbs) has become available directed against various GPI-linked membrane proteins. This makes it possible to study various cell lineages for the deficiency of such proteins in PNH in more detail. Using cytofluorography, we could show that the granulocytes of 20 different PNH patients miss not only GPI-linked FcRIII (CD16 antigen), but also three other GPI-linked proteins, ie, CD24 antigen, CD67 antigen and a granulocyte-specific 50 to 80 Kd antigen. The affected granulocytes were not only neutrophils but also eosinophils, as was found in a more detailed analysis of three patients. Moreover, in all 10 PNH patients tested, the monocytes were found to be deficient for the GPI-linked CD14 antigen, and we found with CD24 and CD55 (DAF) antibodies that lymphocytes may be involved as well. However, abnormal B and T lymphocytes were detected only in a subset of patients (2 of 10 tested). The uniform deficiency of GPI-linked proteins of granulocytes allows the introduction of a new diagnostic cytofluorometric assay for PNH with MoAbs against GPI-linked granulocytic antigens. This test was positive in all PNH patients studied and not in a group of 40 control patients or 50 normal donors, with the exception of three of 16 aplastic anemia (AA) patients. In the three AA patients, subpopulations (10% to 20%) of PNH granulocytes could be detected, whereas these patients had a negative acidified serum (Ham) test. This indicates that the new test is more sensitive than the Ham test and allows the early diagnosis of PNH in AA. An advantage of the neutrophil assay is that, in contrast to the Ham test, it is not influenced by recent red-cell transfusions. Moreover, it is possible to quantify the number of affected cells by single cell analysis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145990

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

Review 1.  Pathogenesis of selective expansion of PNH clones.

Authors:  Hideki Nakakuma; Tatsuya Kawaguchi
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

2.  Multiparameter flow cytometry for the diagnosis and monitoring of small GPI-deficient cellular populations.

Authors:  Minoo Battiwalla; Mehmet Hepgur; Dalin Pan; Philip L McCarthy; Manmeet S Ahluwalia; Susan H Camacho; Petr Starostik; Paul K Wallace
Journal:  Cytometry B Clin Cytom       Date:  2010-06-07       Impact factor: 3.058

3.  Paroxysmal nocturnal hemoglobinuria and eculizumab.

Authors:  Lucio Luzzatto; Antonio Maria Risitano; Rosario Notaro
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

Review 4.  Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia.

Authors:  Amy E DeZern; Robert A Brodsky
Journal:  Hematol Oncol Clin North Am       Date:  2015-03-07       Impact factor: 3.722

5.  DIAGNOSTIC DILEMMAS IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.

Authors:  Rajat Kumar; S Dutta; Harsh Kumar; A I Lazar; V K Sashindran
Journal:  Med J Armed Forces India       Date:  2017-06-27

Review 6.  Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol anchor.

Authors:  E T Yeh; W F Rosse
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

7.  Synthesis and evaluation of Nα,Nε-diacetyl-l-lysine-inositol conjugates as cancer-selective probes for metabolic engineering of GPIs and GPI-anchored proteins.

Authors:  Mohit Jaiswal; Sanyong Zhu; Wenjie Jiang; Zhongwu Guo
Journal:  Org Biomol Chem       Date:  2020-04-15       Impact factor: 3.876

8.  Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents.

Authors:  Antonio M Risitano; Bruno Rotoli
Journal:  Biologics       Date:  2008-06

9.  On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2.

Authors:  P W Parren; P A Warmerdam; L C Boeije; J Arts; N A Westerdaal; A Vlug; P J Capel; L A Aarden; J G van de Winkel
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

10.  New monoclonal antibodies in CD59: use for the analysis of peripheral blood cells from paroxysmal nocturnal haemoglobinuria (PNH) patients and for the quantitation of CD59 on normal and decay accelerating factor (DAF)-deficient erythrocytes.

Authors:  A Fletcher; J A Bryant; B Gardner; P A Judson; F A Spring; S F Parsons; G Mallinson; D J Anstee
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.